Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
GLP-1s still unavailable in lower-income countries: MSF
Médecins Sans Frontières urged GLP-1 drug makers to "relinquish their stranglehold" on the meds and license them to generics makers to boost access.
Zoey Becker
Mar 28, 2024 8:00am
In banner year, Lilly rewards CEO with 24% pay boost to $26.6M
Mar 25, 2024 3:06pm
Lilly CEO reaffirms commitment to Chinese market amid US tension
Mar 22, 2024 11:30am
GLP-1s on track to take drug sales throne from PD-1 inhibitors
Mar 15, 2024 10:54am
GLP-1 sales surge to power industry earnings growth: Moody's
Mar 15, 2024 9:50am
Eli Lilly calls out stars who use GLP-1 drugs to fit in a dress
Mar 11, 2024 11:16am